A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients
NCT02687828
·
clinicaltrials.gov ↗
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Intestinal Behcet's Disease (BD)
Sponsor
AbbVie